Stanley He

Stanley Stanley is an experienced professional currently serving as the Global Analytics & Insights Associate Director at AstraZeneca since August 2024. Previously, Stanley held the position of Chief Business Officer at RNAimmune from June 2020 to August 2024 and worked in business development at Sirnaomics, Inc. from November 2019 to June 2020. Early career roles include positions in healthcare investment at Sigma Square Capital, private equity investment as an Associate at PRINCIPLE CAPITAL LTD, and various consulting roles at American Express, Wearable X, and BloomSky, Inc. Additionally, Stanley is an investor at Taskade, a collaboration tool focused on the distributed workforce, which is part of the Y Combinator S19 batch. Educational qualifications include an MBA from Georgetown University McDonough School of Business and a BS from Babson College.